Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Rozanolixizumab for MOG-AD
Recruiting1 awardPhase 3
Cleveland, Ohio
This trial is testing a medication called rozanolixizumab to see if it can safely and effectively treat adults with a nervous system condition called MOG-AD. The medication aims to reduce harmful antibodies that cause the disease.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service